Gdf-15 levels in patients with polycystic ovary syndrome treated with metformin: a combined clinical and in silico pathway analysis
| dc.creator | Fernanda Medeiros Vale Magalhaes | |
| dc.creator | Rodrigo Mendonça Cardoso Pestana | |
| dc.creator | Cláudia Natália Ferreira | |
| dc.creator | Ieda de Fatima Oliveira Silva | |
| dc.creator | Ana Lúcia Cândido | |
| dc.creator | Flávia Ribeiro Oliveira | |
| dc.creator | Fernando Marcos dos Reis | |
| dc.creator | Karina Braga Gomes | |
| dc.date.accessioned | 2025-07-03T19:43:44Z | |
| dc.date.accessioned | 2025-09-09T01:23:04Z | |
| dc.date.available | 2025-07-03T19:43:44Z | |
| dc.date.issued | 2024 | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.20945/2359-4292-2023-0416 | |
| dc.identifier.issn | 2359-3997 | |
| dc.identifier.uri | https://hdl.handle.net/1843/83319 | |
| dc.language | por | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Archives of endocrinology and metabolism | |
| dc.rights | Acesso Aberto | |
| dc.subject | Growth Differentiation Factor 15 | |
| dc.subject | Polycystic Ovary Syndrome | |
| dc.subject | Metformin | |
| dc.subject.other | Growth Differentiation Factor 15 | |
| dc.subject.other | Polycystic Ovary Syndrome | |
| dc.subject.other | Metformin | |
| dc.subject.other | Biologic pathways | |
| dc.title | Gdf-15 levels in patients with polycystic ovary syndrome treated with metformin: a combined clinical and in silico pathway analysis | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 9 | |
| local.citation.spage | 1 | |
| local.citation.volume | 68 | |
| local.description.resumo | Polycystic ovary syndrome (PCOS) is an endocrine disease characterized by metabolic, reproductive, and psychological manifestations. Growth and differentiation factor 15 (GDF-15) is a cytokine associated with metabolic and inflammatory disorders. Metformin is commonly used for the treatment of PCOS. We investigated the relationship between GDF-15 levels and PCOS, the effect of metformin on GDF-15 levels, and potential biologic pathways related to GDF-15. Subjects and methods: The study included 35 women with PCOS and 32 women without PCOS (controls). Both groups were compared in terms of GDF-15 levels. Additional analysis was conducted on samples from 22 women with PCOS who were treated with either metformin (n = 7) or placebo (n = 15), retrieved from a previous randomized, controlled trial. Levels of GDF-15 were measured using MILLIPLEX. The biologic pathways related to GDF-15 were evaluated using the databases STRING, SIGNOR, and Pathway Commons. The statistical analysis was conducted using the software SPSS. Results: Levels of GDF-15 were higher in the PCOS group compared with the non-PCOS group (p = 0.039). Among women with PCOS, GDF-15 levels were higher in those treated with metformin compared with placebo (p = 0.007). The proteins related to GDF-15 overlapped between the databases, and a significant interaction was found between GDF-15 and proteins related to PCOS and its complications, including those related to estrogen response, oxidative stress, ovarian infertility, interleukin (IL)-18, IL-4, the ratio of advanced glycation end products to their receptor (AGE/RAGE), leptin, transforming growth factor beta (TGF-β), adipogenesis, and insulin. Conclusion: The findings of the present study suggest a relationship between GDF-15 and PCOS and a potential increase in GDF-15 levels with metformin treatment. An additional finding was that GDF-15 could be involved in biologic pathways related to PCOS complications. | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.department | MED - DEPARTAMENTO DE GINECOLOGIA OBSTETRÍCIA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.scielo.br/j/aem/a/GtcSgg8MZBnGgdmFM9TMfns/?format=pdf&lang=en |
Arquivos
Pacote original
1 - 1 de 1
Carregando...
- Nome:
- Gdf-15 levels in patients with polycystic ovary syndrome treated with metformin: a combined clinical and in silico pathway analysis.pdf
- Tamanho:
- 201.72 KB
- Formato:
- Adobe Portable Document Format
Licença do pacote
1 - 1 de 1